Machine-Learning Tool to Improve Clinical Outcomes for Stroke Patients with Large Blood Vessel Blockages
By HospiMedica International staff writers Posted on 11 Oct 2024 |

An ischemic stroke occurs when a blood clot or other particle blocks a blood vessel in the brain. In about one-third of cases, clot-dissolving medications can successfully break up the blockage. However, when the clot is large, medication alone often proves insufficient, leading doctors to consider endovascular therapy. This procedure involves guiding a catheter through an artery in the groin or wrist into the brain to remove the clot. Recent studies suggest that even a day or more after a stroke, and even in cases of extensive damage, patients can still experience positive outcomes from endovascular therapy. Conversely, some patients who are predicted to benefit from this procedure based on specific metrics do not see improvement. While doctors can successfully restore blood flow by unblocking the artery in over 90% of cases, more than 50% of these patients still suffer from moderate to severe disability. A new study aims to bridge the gap between successful vessel reopening via endovascular surgery and reduced post-stroke disability.
The five-year study, to be conducted by researchers at University of Texas Health Science Center at Houston (Houston, TX, USA), will focus on developing a machine-learning tool to predict which stroke patients with large vessel blockages are most likely to benefit from endovascular therapy. The team will create a database of imaging and clinical outcomes from patients at three U.S. hospitals who have undergone successful reperfusion, the process of reopening the blocked vessel. This database will help researchers identify clinical and imaging predictors of brain damage following reperfusion.
The research team will develop a machine-learning model capable of predicting brain tissue viability and clinical outcomes using data collected both before endovascular therapy and after reperfusion. This deep-learning model will incorporate imaging data, patient clinical history, and stroke severity measures to help identify patients for whom endovascular therapy alone may not be enough to produce favorable outcomes. By analyzing changes between pre- and post-treatment imaging and clinical variables, the model will also aim to predict outcomes in patients treated with clot-busting medications and/or endovascular therapy.
“We are letting an algorithm learn the visual features that are predictive to doing well, or not doing well,” said lead investigator Luca Giancardo, PhD, associate professor at UTHealth Houston. “It’s not that machine learning or AI see things that are invisible. They see things that are there. But finding correlations between multiple modalities, with longitudinal data, it’s hard because they can be very subtle. The model is hopefully going to see things that we don’t see, that we don’t think to see, that we wouldn’t even think to analyze in certain ways. So, this model will hopefully be able to outperform what we can do with our eyes.”
Related Links:
UTHealth Houston
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreSurgical Techniques
view channel
Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
Surgical adhesions are a frequent and often life-threatening complication following open or laparoscopic abdominal surgery. These adhesions develop in the weeks following surgery as the body heals.... Read more
Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
Leadless pacemakers marked a significant advancement in cardiac care, primarily because traditional pacemakers are dependent on leads, which are prone to breakage over time. Currently, two FDA-approved... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more